Reblozyl Archives -

After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5

Merck confirms $11.5bn Acceleron takeover deal

https://pharmaphorum.com/news/merck-confirms-11-5bn-acceleron-takeover-deal/

US biopharma company Acceleron is the next company heading for a takeover by a big pharma group –

Rumour mill says Acceleron is speeding towards $11bn sale

https://pharmaphorum.com/news/rumour-mill-says-acceleron-is-speeding-towards-11bn-sale/

Bristol-Myers Squibb has taken another step towards achieving its blockbuster hopes for beta thalassaemia-associated anaemia therapy Reblozyl, after

EHA21: Study raises BMS’ hopes for Reblozyl in less severe disease

https://pharmaphorum.com/news/eha21-study-raises-bms-hopes-for-reblozyl-in-less-severe-patients/

Reblozyl